Founded in 2007, Endomedix Kft. is one of the country's leading private gastroenterology providers. At Endomedix centres in 9 locations across the country, a wide range of gastroenterology services is available, from consultations all the way to complex procedures such as gastroscopy and colonoscopy under anaesthesia.

The Endomedix its well-known health protection and prevention programmes as well; so far, around 9,600 patients have taken part in the company's home colorectal cancer screening programme.

The Endomedix in addition, it plays an undisputed leading role in food intolerance testing in Hungary – so far we have tested more than ten thousand patients with our automated food intolerance test – more than all of Endomedix's competitors combined.

Building on our professional experience in food intolerance, we set our sights on new areas of development: following our successful application to the GINOP-2.1.2 call, in March 2018 we began developing a new dietary supplement with an innovative composition, including the detailed development of the formulation and production technology, obtaining the first notification valid for European Union countries, and conducting a comprehensive clinical trial demonstrating its efficacy.

The Endomedix research carried out at its two sites was completed on 19 December 2020, and you can find out about the project's results through many channels (events, the print and digital press, our websites and professional articles). If you have any questions about the project, please feel free to contact us!

Beneficiary: Endomedix Kft.

Project title: Development and clinical testing of an innovative dietary supplement

Project code: GINOP-2.1.2-8-1-4-16-2017-00109

Amount of non-repayable grant: 127,83 million Ft (55%)

Amount of repayable support: 81,35 million Ft (35%)

Project completion: 2020.12.19.